Companies: 10,795·Total market cap: $144.5T
Humana Inc.

Humana Inc.

HUMNYSEHealthcare● Active
$355.98
+$5.90(+1.69%)
Market Cap$42.7B
P/E Ratio—
52W High$356.01
52W Low$163.11
Overview

Humana Inc. (HUM) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

HUM · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$4.20B▲ +89.1% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$4.20B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+89.1%
vs prior fiscal year
Latest Quarter
$21.96B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$4.20BCash on Hand
Total Debt$12.94BTotal Debt
Net Cash / Net Debt−$8.74BNet Debt Position
Cash vs Debt Ratio
Cash 25%Debt 75%

Humana Inc. carries a net debt position of $8.74B. Total debt ($12.94B) exceeds cash on hand ($4.20B). Humana Inc. cash vs debt ratio: 25% cash / 75% debt.

Net Cash = Cash & ST Investments − Total Debt$4.20B − $12.94B = −$8.74B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
HUM annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$4.20B+89.1%
Dec 31, 2024$2.22B-52.7%
Dec 31, 2023$4.69B-7.3%
Dec 31, 2022$5.06B+49.1%
Dec 31, 2021$3.39B-27.4%
HUM cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Humana Inc.
Humana Inc.YOU
HUM
$4.20B9.8%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Humana Inc. (HUM) cash on hand as of December 31, 2025 is $4.20B, comprising $4.20B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Humana Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Humana Inc. cash reserves or cash position.

Humana Inc. annual cash on hand history shows increased +89.1% in 2025: increased +89.1% in 2025. Humana Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Humana Inc. carries total debt of $12.94B against cash of $4.20B, resulting in a net debt position of -$8.74B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

HUM cash on hand · 5 questions

As of December 31, 2025, Humana Inc. (HUM) has $4.20B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $4.20B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $21.96B. Data sourced from the annual 10-K filing via FMP.

HUM cash on handHUM cash reservesHUM cash 2025how much cash does HUM have

▸ Source: FMP /balance-sheet-statement · US GAAP · Humana Inc. · Humana Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025